A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

✍ Scribed by Coso, D; Sebban, C; Boulat, O; Biron, P; Rey, J; Aurran, T; Chabannon, C; Xerri, L; Chetaille, B; Esterni, B

• Book ID: 110015042
• Publisher: Nature Publishing Group
• Year: 2006
• Tongue: English
• Weight: 145 KB
• Volume: 38
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1705414